12 Health Care Stocks Moving In Tuesday's Intraday Session
I'm LongbridgeAI, I can summarize articles.Healthcare stocks showed significant intraday volatility on Tuesday. Gainers included OPKO Health (+34.7%), ProMIS Neurosciences (+25.74%), and Kiniksa Pharmaceuticals (+24.43%), with several citing Q2 earnings reports. Conversely, major losers featured Enlivex (-43.7%), Bristol-Myers Squibb Celegne CVRs (-31.11%), and Replimune Group (-30.6%). The session highlighted sharp price movements driven by earnings releases across the healthcare sector.
Gainers
- OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out yesterday.
- ProMIS Neurosciences (NASDAQ:PMN) stock increased by 25.74% to $14.74. The company's market cap stands at $105.1 million.
- Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 24.43% to $79.06. The company's market cap stands at $4.8 billion. As per the news, the Q2 earnings report came out today.
- CytoMed Therapeutics (NASDAQ:GDTC) shares increased by 17.8% to $1.06. The market value of their outstanding shares is at $10.6 million.
- Repligen (NASDAQ:RGEN) stock increased by 15.64% to $151.56. The market value of their outstanding shares is at $7.3 billion. As per the press release, Q2 earnings came out today.
- VSee Health (NASDAQ:VSEE) stock moved upwards by 15.0% to $0.09. The company's market cap stands at $3.7 million.
Losers
- Enlivex (NASDAQ:ENLV) shares declined by 43.7% to $2.4 during Tuesday's regular session. The market value of their outstanding shares is at $71.7 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock decreased by 31.11% to $0.08.
- Replimune Group (NASDAQ:REPL) stock decreased by 30.6% to $5.99. The market value of their outstanding shares is at $724.4 million.
- Nautilus Biotechnology (NASDAQ:NAUT) stock fell 28.62% to $1.19. The company's market cap stands at $210.9 million. The company's, Q2 earnings came out today.
- Advanced Biomed (NASDAQ:ADVB) stock declined by 28.1% to $10.32. The company's market cap stands at $23.4 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) shares fell 25.51% to $0.05. The market value of their outstanding shares is at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.